Refine by MP, party, committee, province, or result type.

Results 1-15 of 69
Sorted by relevance | Sort by date: newest first / oldest first

Physician-Assisted Dying committee  That quality of access and availability of access are critical, as far as you're concerned.

February 4th, 2016Committee meeting

James S. Cowan

Physician-Assisted Dying committee  The co-chair mentioned to you, Mr. Chipeur, the practice advisory that came. It's my understanding, and I just want to make sure that I understand this clearly, that you're not suggesting that the regime which Chief Justice Smith has proposed is required by the Carter decision it

February 4th, 2016Committee meeting

James S. Cowan

Physician-Assisted Dying committee  I'm not suggesting that we couldn't go there, but I'm also taking you as not suggesting that we would be required to go there in order to meet the Carter decision.

February 4th, 2016Committee meeting

James S. Cowan

Physician-Assisted Dying committee  I think that those are all the questions that I had. I did have one statement that I wanted to get on the record. It tends not to do with this, but as long as I could have a minute at the end—

February 4th, 2016Committee meeting

James S. Cowan

Physician-Assisted Dying committee  If colleagues wanted to ask questions of these witnesses, I—

February 4th, 2016Committee meeting

James S. Cowan

Physician-Assisted Dying committee  It was just a point of clarification, perhaps. Colleagues will recall that yesterday we had pediatric specialists here, and the suggestion was made that the provincial-territorial panel did not have access to pediatric expertise, that no witnesses were called, or that the aspec

February 4th, 2016Committee meeting

James S. Cowan

Physician-Assisted Dying committee  Thank you to all the presenters. We've had very interesting and very important evidence. Dr. Stern, I wanted to go to the issue of the decision-making process. You described it as the CMPA supporting a decision-making process that will be easily accessible to patients, respect p

February 4th, 2016Committee meeting

James S. Cowan

Physician-Assisted Dying committee  I want to switch to the issue of advance directives. You're familiar with the recommendations that have been made by the provincial-territorial panel as to the various levels and different categories. Is it your view with respect to advance directives that there must be competenc

February 4th, 2016Committee meeting

James S. Cowan

Physician-Assisted Dying committee  Ms. Birrell, I thought you wanted to interject.

February 4th, 2016Committee meeting

James S. Cowan

Physician-Assisted Dying committee  You mean even if the patient had lost, as one would in that case, the capacity between the time of the original execution of the declaration and the time the assistance was administered. Is that correct?

February 4th, 2016Committee meeting

James S. Cowan

Physician-Assisted Dying committee  Thank you. Thank you to the witnesses for being here. It is very helpful. I want to pursue with Mr. Gunn the same points that Senator Seidman and Mr. Rankin were talking about, and that is the difference between your approach, a minimalist federal framework supported by what y

February 4th, 2016Committee meeting

James S. Cowan

Physician-Assisted Dying committee  My questions are for the Canadian Paediatric Society as well. In your presentation, you talked about the first iteration and the need to be very careful if we are to go beyond the adult capacity to younger persons. I was reading the bioethics committee's practice point document,

February 3rd, 2016Committee meeting

James S. Cowan

Physician-Assisted Dying committee  Okay. How do you square that circle? How do you reconcile the presentation that you're making here tonight, urging us to be very careful and not to go beyond...above the floor, if you like, with the document that was originally posted in 2011 and then reaffirmed just the other

February 3rd, 2016Committee meeting

James S. Cowan

Physician-Assisted Dying committee  So is that the basis for your distinction, on whether or not the illness is terminal?

February 3rd, 2016Committee meeting

James S. Cowan

February 3rd, 2016Committee meeting

James S. Cowan